Kolon Life Science Inc.

KOSDAQ:A102940 Stock Report

Market Cap: ₩239.7b

Kolon Life Science Balance Sheet Health

Financial Health criteria checks 3/6

Kolon Life Science has a total shareholder equity of ₩159.7B and total debt of ₩122.7B, which brings its debt-to-equity ratio to 76.9%. Its total assets and total liabilities are ₩350.7B and ₩191.0B respectively.

Key information

76.9%

Debt to equity ratio

₩122.74b

Debt

Interest coverage ration/a
Cash₩8.39b
Equity₩159.69b
Total liabilities₩191.01b
Total assets₩350.70b

Recent financial health updates

Recent updates

Risks Still Elevated At These Prices As Kolon Life Science Inc. (KOSDAQ:102940) Shares Dive 26%

Mar 02
Risks Still Elevated At These Prices As Kolon Life Science Inc. (KOSDAQ:102940) Shares Dive 26%

We Think Kolon Life Science (KOSDAQ:102940) Has A Fair Chunk Of Debt

Mar 12
We Think Kolon Life Science (KOSDAQ:102940) Has A Fair Chunk Of Debt

A Look At Kolon Life Science's (KOSDAQ:102940) Share Price Returns

Jan 18
A Look At Kolon Life Science's (KOSDAQ:102940) Share Price Returns

Kolon Life Science (KOSDAQ:102940) Is Carrying A Fair Bit Of Debt

Nov 26
Kolon Life Science (KOSDAQ:102940) Is Carrying A Fair Bit Of Debt

Financial Position Analysis

Short Term Liabilities: A102940's short term assets (₩113.6B) do not cover its short term liabilities (₩141.1B).

Long Term Liabilities: A102940's short term assets (₩113.6B) exceed its long term liabilities (₩50.0B).


Debt to Equity History and Analysis

Debt Level: A102940's net debt to equity ratio (71.6%) is considered high.

Reducing Debt: A102940's debt to equity ratio has increased from 74.1% to 76.9% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: A102940 has sufficient cash runway for 2 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: A102940 is forecast to have sufficient cash runway for 3 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.